MedTrace Logo

EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression

NCT04266431 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-02-12

No results posted yet for this study

Summary

This study will evaluate whether a lifestyle intervention focused on weight loss, EMPOWER, reduces prostate cancer progression at 12 months among men with biochemical recurrence following local treatment for prostate cancer. Half of the men will be randomized to receive the EMPOWER intervention, while the other half will receive standard of care.

Conditions

  • Prostatic Neoplasm

Interventions

BEHAVIORAL

EMPOWER

Behavioral weight loss intervention

Sponsors & Collaborators

  • American Cancer Society, Inc.

    collaborator OTHER

  • Maryland Cigarette Restitution Fund

    collaborator OTHER_GOV

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    lead OTHER

Principal Investigators

  • Corinne Joshu, PhD · Johns Hopkins Bloomberg School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-20
Primary Completion
2024-05-31
Completion
2025-02-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04266431 on ClinicalTrials.gov